# SOLIRIS

NDC: 25682-001
Generic name: ECULIZUMAB
Labeler / Manufacturer: Alexion Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20070402

FDA application: BLA125166

## Active ingredients

- ECULIZUMAB: 300 mg/30mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25682-001"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25682-001
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722